Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

Delayed Quote. Delayed  - 05/25 09:59:59 pm
32.89 USD   -1.97%
05/10 NATUS MEDICAL : to Present at UBS Global Healthcare Conference
05/09 Natus to Present at UBS Global Healthcare Conference
04/28 INVESTGIATION F : BABY) over Possible Wrongdoing
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 01:05pm CEST

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
InvestorRelations@Natus.com
Vice President and Chief Financial Officer


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on NATUS MEDICAL INC
05/13 NATUS MEDICAL : Special Notice - aEEG Brain Monitor
05/10 NATUS MEDICAL : to Present at UBS Global Healthcare Conference
05/09 Natus to Present at UBS Global Healthcare Conference
04/28 INVESTGIATION FOR INVESTORS IN SHARE : BABY) over Possible Wrongdoing
04/23 ATTENTION NATUS SHAREHOLDERS : Shareholder Rights Law Firm Johnson & Weaver, LLP..
04/22 NATUS MEDICAL : Hagens Berman Investigates Natus Medical Inc.’s Guidance o..
04/20 NATUS MEDICAL : beats 1Q profit forecasts
04/20 Natus Medical Announces Record First Quarter 2016 Financial Results
04/16 NATUS MEDICAL : NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suff..
04/15 NATUS MEDICAL : Goldberg Law PC Announces an Investigation of Claims against Nat..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials